Catalyst Wire Dossier Catalyst Wire Dossier

Vimpat (lacosamide)

lacosamide · UCB Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vimpat (lacosamide), covering 2012-05-15 to 2012-05-15. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain [Phase 2]

See pricing